Invention Grant
- Patent Title: Bioresorbable ocular drug delivery device
-
Application No.: US16095680Application Date: 2017-04-20
-
Publication No.: US11318043B2Publication Date: 2022-05-03
- Inventor: Harold Alexander Heitzmann , David Steven Haffner , Kenneth Martin Curry , Thomas W. Burns
- Applicant: Harold Alexander Heitzmann , David Steven Haffner , Kenneth Martin Curry , Thomas W. Burns
- Applicant Address: US CA Irvine; US CA Mission Viejo; US CA Oceanside; US CA Dana Point
- Assignee: Harold Alexander Heitzmann,David Steven Haffner,Kenneth Martin Curry,Thomas W. Burns
- Current Assignee: Harold Alexander Heitzmann,David Steven Haffner,Kenneth Martin Curry,Thomas W. Burns
- Current Assignee Address: US CA Irvine; US CA Mission Viejo; US CA Oceanside; US CA Dana Point
- Agency: Knobbe, Martens, Olson & Bear LLP
- International Application: PCT/US2017/028665 WO 20170420
- International Announcement: WO2017/184881 WO 20171026
- Main IPC: A61F9/00
- IPC: A61F9/00

Abstract:
An ocular implant configured for implantation into the eye of a subject comprising an elongate outer shell (54), an internal plug (210) including a hydrogel and a drug reservoir including a drug (62) wherein the drug is configured to pass through at least a portion of the internal plug to control elution of the drug through the outer shell. The implant is made of biodegradable materials.
Public/Granted literature
- US20190125581A1 BIORESORBABLE OCULAR DRUG DELIVERY DEVICE Public/Granted day:2019-05-02
Information query